BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38373638)

  • 21. [Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: report of one case].
    Vega J; Goecke H; Rodríguez Mde L; Vergara MT
    Rev Med Chil; 2011 Jul; 139(7):909-13. PubMed ID: 22051829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and security of thalidomide for gastrointestinal bleeding and severe Crohn's disease in children].
    Bauditz J
    Z Gastroenterol; 2014 Oct; 52(10):1198-201. PubMed ID: 25313632
    [No Abstract]   [Full Text] [Related]  

  • 23. Thalidomide for treatment of bleeding angiodysplasias during hemodialysis.
    Mimidis K; Kaliontzidou M; Tzimas T; Papadopoulos V
    Ren Fail; 2008; 30(10):1040-1. PubMed ID: 19016158
    [No Abstract]   [Full Text] [Related]  

  • 24. In small-intestinal angiodysplasia with recurrent bleeding, thalidomide reduced bleeding episodes at 1 y.
    Hakim A; Feuerstein JD
    Ann Intern Med; 2024 Mar; 177(3):JC32. PubMed ID: 38437700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel Use of Thalidomide in Recurrent Gastrointestinal Tract Bleeding in Patients with Left Ventricular Assist Devices: A Case Series.
    Chan LL; Lim CP; Lim CH; Tan TE; Sim D; Sivathasan C
    Heart Lung Circ; 2017 Oct; 26(10):1101-1104. PubMed ID: 28131776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias.
    Garrido A; Sayago M; López J; León R; Bellido F; Márquez JL
    Rev Esp Enferm Dig; 2012 Feb; 104(2):69-71. PubMed ID: 22372800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of thalidomide in digestive bleeding caused by angiodysplasias].
    Fernández Salazar LI; Velayos Jiménez B; Fernández Galante I; Aller de la Fuente R; González Hernández JM
    Rev Esp Enferm Dig; 2009 May; 101(5):371. PubMed ID: 19527086
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pulmonary hypertension in a patient with talidomide].
    Hurtado García R; García Rodríguez M
    Farm Hosp; 2013; 37(3):267-9. PubMed ID: 23789805
    [No Abstract]   [Full Text] [Related]  

  • 29. Refractory bleeding from portal hypertensive gastropathy: a further novel role for thalidomide therapy?
    Karajeh MA; Hurlstone DP; Stephenson TJ; Ray-Chaudhuri D; Gleeson DC
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):545-8. PubMed ID: 16607153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding.
    Bauditz J; Lochs H
    World J Gastroenterol; 2007 Dec; 13(45):5979-84. PubMed ID: 18023086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of thalidomide in the management of bleeding from a gastric cancer.
    Lambert K; Ward J
    Palliat Med; 2009 Jul; 23(5):473-5. PubMed ID: 19304809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of thalidomide for recurrent bleeding due to gastric angiodysplasia in hereditary hemorrhagic telangiectasia.
    Wang XY; Chen Y; Du Q
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1114-6. PubMed ID: 23661527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic failure with thalidomide in patients with recurrent intestinal bleeding due to angiodysplasias.
    Izquierdo Navarro Mdel C; Hernando Verdugo M; Cardaba Garcia E; Sanchez Sanchez MT
    Farm Hosp; 2016 May; 40(3):230-2. PubMed ID: 27145393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide.
    Bauditz J; Lochs H; Voderholzer W
    Endoscopy; 2006 Oct; 38(10):1036-9. PubMed ID: 17058171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.
    Chen H; Fu S; Feng N; Chen H; Gao Y; Zhao Y; Xue H; Zhang Y; Li X; Dai J; Fang J; Ge Z
    Medicine (Baltimore); 2016 Aug; 95(33):e4606. PubMed ID: 27537596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
    Alam MA; Sami S; Babu S
    BMJ Case Rep; 2011 Nov; 2011():. PubMed ID: 22674103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia?
    Pérez-Encinas M; Rabuñal Martínez MJ; Bello López JL
    Haematologica; 2002 Aug; 87(8):ELT34. PubMed ID: 12161379
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thalidomide associated to endoscopic treatment with argon plasma coagulation in rectal bleeding caused by vascular injury secundary to severe actinic proctitis].
    Pizarro Moreno A; Garzón Benavides M; Araujo Miguez A; Bozada García JM
    Med Clin (Barc); 2012 Oct; 139(8):369-70. PubMed ID: 22498348
    [No Abstract]   [Full Text] [Related]  

  • 39. Thalidomide in angiodysplasia-related bleeding.
    Boey JP; Hahn U; Sagheer S; McRae SJ
    Intern Med J; 2015 Sep; 45(9):972-6. PubMed ID: 26332623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel use of low-dose thalidomide in refractory gastrointestinal bleeding in left ventricular assist device patients.
    Seng BJJ; Teo LLY; Chan LL; Sim DKL; Kerk KL; Soon JL; Tan TE; Sivathasan C; Lim CP
    Int J Artif Organs; 2017 Oct; 40(11):636-640. PubMed ID: 28708213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.